These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 27301196)

  • 1. Folate-Modified Chitosan Nanoparticles Coated Interferon-Inducible Protein-10 Gene Enhance Cytotoxic T Lymphocytes' Responses to Hepatocellular Carcinoma.
    Duan S; Song M; He J; Zhou N; Zhou S; Zhao J; Fang Y; Yi P; Huang X; Luo G; Lai C; Yu X; Zhang Z; Xie Y; Zhao Y; Lu X
    J Biomed Nanotechnol; 2016 Apr; 12(4):700-9. PubMed ID: 27301196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-tumor immune response of folate-conjugated chitosan nanoparticles containing the IP-10 gene in mice with hepatocellular carcinoma.
    Lai C; Yu X; Zhuo H; Zhou N; Xie Y; He J; Peng Y; Xie X; Luo G; Zhou S; Zhao Y; Lu X
    J Biomed Nanotechnol; 2014 Dec; 10(12):3576-89. PubMed ID: 26000371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folate-modified Chitosan Nanoparticles Containing the IP-10 Gene Enhance Melanoma-specific Cytotoxic CD8(+)CD28(+) T Lymphocyte Responses.
    He J; Duan S; Yu X; Qian Z; Zhou S; Zhang Z; Huang X; Huang Y; Su J; Lai C; Meng J; Zhou N; Lu X; Zhao Y
    Theranostics; 2016; 6(5):752-61. PubMed ID: 27022421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse IP-10 Gene Delivered by Folate-modified Chitosan Nanoparticles and Dendritic/tumor Cells Fusion Vaccine Effectively Inhibit the Growth of Hepatocellular Carcinoma in Mice.
    Hu Z; Chen J; Zhou S; Yang N; Duan S; Zhang Z; Su J; He J; Zhang Z; Lu X; Zhao Y
    Theranostics; 2017; 7(7):1942-1952. PubMed ID: 28638480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced cytotoxic T lymphocytes recruitment targeting tumor vasculatures by endoglin aptamer and IP-10 plasmid presenting liposome-based nanocarriers.
    Yang X; Zhao J; Duan S; Hou X; Li X; Hu Z; Tang Z; Mo F; Lu X
    Theranostics; 2019; 9(14):4066-4083. PubMed ID: 31281532
    [No Abstract]   [Full Text] [Related]  

  • 6. A constructed HLA-A2-restricted pMAGE-A1(278-286) tetramer detects specific cytotoxic T lymphocytes in tumour tissues in situ.
    Mongkhoune S; Xie YA; Wang YQ; Chen Y; Zhou N; Peng Y; He J; Yu X; Zhou SF; Luo GR; Zhao YX; Lu XL
    J Int Med Res; 2013 Dec; 41(6):1811-24. PubMed ID: 24071590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered cytotoxic T lymphocytes with AFP-specific TCR gene for adoptive immunotherapy in hepatocellular carcinoma.
    Sun L; Guo H; Jiang R; Lu L; Liu T; He X
    Tumour Biol; 2016 Jan; 37(1):799-806. PubMed ID: 26250457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adoptive transfer of type 1 CTL mediates effective anti-central nervous system tumor response: critical roles of IFN-inducible protein-10.
    Nishimura F; Dusak JE; Eguchi J; Zhu X; Gambotto A; Storkus WJ; Okada H
    Cancer Res; 2006 Apr; 66(8):4478-87. PubMed ID: 16618775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human IP10-scFv and DC-induced CTL synergistically inhibit the growth of glioma in a xenograft model.
    Wang X; Zhang FC; Zhao HY; Lu XL; Sun Y; Xiong ZY; Jiang XB
    Tumour Biol; 2014 Aug; 35(8):7781-91. PubMed ID: 24816916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effect of adoptive T-cell therapy and intratumoral interferon gamma-inducible protein-10 transgene expression in treatment of established tumors.
    Huang H; Liu Y; Xiang J
    Cell Immunol; 2002; 217(1-2):12-22. PubMed ID: 12425997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic carcinoma-specific immunotherapy using novel tumor specific cytotoxic T cells.
    Lei J; Wu Z; Jiang Z; Li J; Zong L; Chen X; Duan W; Xu Q; Zhang L; Han L; Ma Q; Wang Z; Zhang D
    Oncotarget; 2016 Dec; 7(50):83601-83610. PubMed ID: 27876704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor eradication by hepatitis B virus X antigen-specific CD8+ T cells in xenografted nude mice.
    Chun E; Lee J; Cheong HS; Lee KY
    J Immunol; 2003 Feb; 170(3):1183-90. PubMed ID: 12538674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trimethyl chitosan based conjugates for oral and intravenous delivery of paclitaxel.
    He R; Yin C
    Acta Biomater; 2017 Apr; 53():355-366. PubMed ID: 28189812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental and clinical research of cytolytic T lymphocytes specific for hepatocellular carcinoma].
    Shen F; Wang H; Xie T
    Zhonghua Wai Ke Za Zhi; 1997 Feb; 35(2):95-9. PubMed ID: 10374486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folate-Modified Poly(malic acid) Graft Polymeric Nanoparticles for Targeted Delivery of Doxorubicin: Synthesis, Characterization and Folate Receptor Expressed Cell Specificity.
    Yang Y; Li N; Nie Y; Sheng M; Yue D; Wang G; Tang JZ; Gu Z
    J Biomed Nanotechnol; 2015 Sep; 11(9):1628-39. PubMed ID: 26485931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artificial antigen-presenting cells expressing AFP(158-166) peptide and interleukin-15 activate AFP-specific cytotoxic T lymphocytes.
    Sun L; Guo H; Jiang R; Lu L; Liu T; Zhang Z; He X
    Oncotarget; 2016 Apr; 7(14):17579-90. PubMed ID: 27007051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of murine tumour growth through CD8
    Kogo H; Shimizu M; Negishi Y; Uchida E; Takahashi H
    Immunology; 2017 Jul; 151(3):324-339. PubMed ID: 28294313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combinations of tumor-specific CD8+ CTLs and anti-CD25 mAb provide improved immunotherapy.
    Ohmura Y; Yoshikawa K; Saga S; Ueda R; Kazaoka Y; Yamada S
    Oncol Rep; 2008 May; 19(5):1265-70. PubMed ID: 18425386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERAP1-Dependent Antigen Cross-Presentation Determines Efficacy of Adoptive T-cell Therapy in Mice.
    Schmidt K; Keller C; Kühl AA; Textor A; Seifert U; Blankenstein T; Willimsky G; Kloetzel PM
    Cancer Res; 2018 Jun; 78(12):3243-3254. PubMed ID: 29559473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective method of chitosan-coated alginate nanoparticles for target drug delivery applications.
    Wang F; Yang S; Yuan J; Gao Q; Huang C
    J Biomater Appl; 2016 Jul; 31(1):3-12. PubMed ID: 27164869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.